Chapter 4 | Part 3: The Unexpected Visitor
A few days passed in the hospital. Some of my friends came to visit. The mix of people who came to visit was interesting, too.
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
A few days passed in the hospital. Some of my friends came to visit. The mix of people who came to visit was interesting, too.
Mesothelioma is best known as the cancer associated with exposure to asbestos. A lesser known fact about mesothelioma is that the period between the exposure/s
by Ann Toney On July 2, 2013, I checked myself into an ER, but not the one I worked in. I wanted to be in
We are deeply saddened by Tara DeAugustinis’ passing. Tara and her husband Rich have become symbols of strength in the mesothelioma community, as they shared their story with the world. Through regular updates beginning with Tara’s diagnosis in early 2016, they informed us of their joys and successes, setbacks and heartbreaks. They taught us that even in the darkest moments life has some light in store. They inspired us with their courage, kindness, honesty and positivity.
oday was one of the best and worst days of my life. At noon I had the opportunity to watch my daughter receive an incredible honor at school. She received Wesleyan’s “Outstanding Achievement Award” for 9th grade girls.
by Jadmin Mostel, Patient Support and Research Assistant, Mesothelioma Applied Research Foundation This past March, I attended the National Comprehensive Cancer Network (NCCN) annual conference,
Hello to all my supporters and prayer warriors! This is Tara and I want to give you a quick update. As Rich wrote the last update six weeks ago, I had just started the tazemetostat clinical trial. Since then I have had 4 more trips to NYC with the most recent being this week.
With the passage of the Omnibus budget bill last week, mesothelioma research will now be eligible for $60 million, an increase of $10 million over